1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency

Drug Use in Renal Insufficiency

136 - 150 of 211 Results
Sort Results:
Guideline: 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines November 2013
PL Voices: Gliptins and Cardiovascular Risk November 2013
Article: bigger emphasis on preventing hospital admissions for heart failure November 2013
Article: Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes November 2013
Article: Many patients don't get appropriate med DOSES after a heart attack October 2013
Article: stronger warnings about peripheral neuropathy with oral or IV quinolone antibiotics October 2013
Patient Education: Heart Failure Meds and More October 2013
Chart: Target Doses of Post-MI Medications October 2013
Commentary: Hormonal Contraception September 2013
Article: Nesina (nes-SEE-na, alogliptin) will compete for your prescription in a crowded market of gliptins for type 2 diabetes August 2013
PL Voices: Adherence with the New Oral Anticoagulants July 2013
Article: boxed warning about stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban) in atrial fib patients July 2013
Patient Education: Why It’s Important to Take Your Blood Thinning Meds June 2013
Article: Invokana (in-vo-KAHN-uh, canagliflozin), the first in a new class of oral drugs for type 2 diabetes May 2013
Commentary: New Drug: Invokana (Canagliflozin) May 2013